# SeaLink Capital Partners

SeaLink Capital Partners is a Private Equity based in Mumbai, India.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Mumbai, India
- **Region:** Asia
- **Address:** Mumbai, India
- **Founded:** 2015
- **Assets under management:** Undisclosed
- **Website:** sealinkcap.com
- **LinkedIn:** https://www.linkedin.com/company/sealink-capital-partners

## Regulatory record

- **Reports private funds:** No

## About

Sealink Capital Partners is a private equity fund focused on mid-sized Indian companies in select industries. The firm has made 9 investments, including a Series D investment in Clove Dental on November 09, 2022. Sealink Capital Partners has 3 portfolio exits, with NephroPlus exiting on December 17, 2025.

## Sectors

- Healthcare Services
- Enterprise Software
- Mobility & Transportation

## Offices

- Dubai
- New York: Coming Shortly

## People

- Heramb Hajarnavis — Founder & Managing Partner
- Karthik Narayanaswamy — Partner
- Rahul Sanghavi — Partner

## Questions

### How does SeaLink Capital Partners source proprietary deal flow?

SCP sources through direct founder relationships and deep sector networks in Indian healthcare and technology, with a stated preference for entrepreneurs who have high integrity standards. Testimonials from portfolio company leaders indicate the firm builds relationships over extended pre-investment periods, and its active post-investment board involvement generates referral flow from existing founders and industry executives.

### What investment stages does SeaLink Capital Partners typically target?

SCP targets growth-stage companies with strong competitive differentiation and proven business models, not seed or early-stage startups. The firm's known investments — Surya Hospitals, Global Dental Services, THB, Ki Mobility, and the prior NephroPlus position — are all established operating businesses with material revenue and market presence at the time of investment.

### How does SeaLink Capital Partners approach post-investment operational engagement?

SCP's model is unusual for a growth-equity firm: it embeds partners into board governance and actively drives operational initiatives. At NephroPlus, SCP led work on employee compensation structures, ESOP allocation, pricing strategy, pharmacy revenue improvements, and inorganic acquisitions. At Surya Hospitals, founder Dr. B.S. Avasthi noted the firm is "very actively involved in our operations" and that "debates and discussions" helped improve hospital performance — a level of engagement more typical of control buyout firms than minority growth investors.

## Related profiles

- [Sealed Air Corporation US Pension Plan](https://altss.com/profile/sealed-air-corporation-us-pension-plan)
- [Seam Investments](https://altss.com/profile/seam-investments)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/sealink-capital-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology